Samuel Preston

8PUBLICATIONS
65CO-AUTHORS
Molecular targetsRespiratory diseasesCancer therapy (excl. chemotherapy and radiation therapy)Liquid biopsiesHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Feb 18, 2026
RAB1A is a novel vulnerability in uveal melanoma revealed by dual inhibition of MNK1/2 and mTOR.

Raúl E Flores-González, Christophe Goncalves, Noah Wirasinghe

|Dec 09, 2025
Dietary restriction reprograms CD8+ T cell fate to enhance anti-tumour immunity and immunotherapy responses.

Brandon M Oswald, Lisa M DeCamp, Joseph Longo

|Sep 13, 2024
Blocking tumor-intrinsic MNK1 kinase restricts metabolic adaptation and diminishes liver metastasis.

Samuel E J Preston, Michael S Dahabieh, Raúl Ernesto Flores González

|Jan 28, 2022
Acquired Resistance to EZH2 Inhibitor GSK343 Promotes the Differentiation of Human DLBCL Cell Lines toward an ABC-Like Phenotype.

Samuel E J Preston, Audrey Emond, Filippa Pettersson

Pageof 2